WEST LAFAYETTE, Ind., March 18, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced the company's management team will host an Investor and Analyst Day on Friday, March 22, 2013, from 9:30 a.m. to 1 p.m. EDT at The Setai Fifth Avenue in New York City.
